Impact of anti-tachycardia pacing on atrial fibrillation burden when added on top of preventive pacing algorithms: Results of the prevention or termination (POT) trial

Europace

Volumn 10, Issue 1, 2008, Pages 28-34

  Mont, Lluís ^a   Ruiz Granell, Ricardo ^b   Martínez, Juan Gabriel ^c   Carmona, José Ramon ^d   Fidalgo, Marisa ^e   Cobo, Erik ^f   Riera, Mireia ^g   Navarro, Xavier ^g  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^d Universidad Pública de Navarra   (Spain)

^e HOSPITAL DE LEÓN   (Spain)

^f UNIVERSITAT POLITÈCNICA DE CATALUNYA   (Spain)

^g Scientific and Clinical Department   (Spain)

Author keywords

Anti tachycardia pacing; AT500; ATP; Atrial fibrillation burden; POT trial; Preventive pacing algorithms

Indexed keywords

ADULT; AGED; ALGORITHM; ANTITACHYCARDIA PACING; ARTICLE; ARTIFICIAL HEART PACEMAKER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TREATMENT INDICATION; TREATMENT OUTCOME; HEART PACING; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; TACHYCARDIA;

AGED; ALGORITHMS; ATRIAL FIBRILLATION; CARDIAC PACING, ARTIFICIAL; CROSS-OVER STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; TACHYCARDIA; TREATMENT OUTCOME;

EID: 40349113522     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eum268     Document Type: Article

References (26)

1. Andersen HR, Nielsen JC, Thomsen PEB, Thuesen L, Mortensen PT, Vesterlund T et al. Long-term follow-up of patients from a randomized trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet 1997;350:1210-6.
2. Gillis AM. Pacing to prevent atrial fibrillation. Cardiol Clin 2000;18:25-36.
3. Carlson MD, Ip J, Messenger J, Beau S, Kalbfleisch S, Gervais P et al. Arial dynamic overdrive pacing trial (ADOPT) investigators. A new pacemaker algorithm for the treatment of atrial fibrillation. Results of the atrial dynamic overdrive pacing trial (ADOPT). J Am Coll Cardiol 2003;42:627-33.
4. Lewalter T, Yang A, Pfeiffer D, Ruiter J, Schnitzler G, Markert T et al. Individualized selection of pacing algorithms for the prevention of recurrent atrial fibrillation: results from the VIP registry. Pacing Clin Electrophysiol 2006;29:124-34.
5. Pürerfellner H, Ruiter JH, Widdershoven JWMNG, Van Gelder IC, Urban L, Kirchhof CJ et al. PMOP Investigators. Reduction of atrial tachyarrhythmia episodes during the overdrive-pacing period using the post-mode switch overdrive pacing (POMP) algorithm. Heart Rhythm 2006;31:164-1171.
6. Daoud EG, Nademanee K, Fuenzalida C, Tomassoni GF, Schuger C, Chisner M et al. Clinical experience with tiered atrial therapies and atrial arrhythmia prevention algorithms in a dual chamber cardioverter defibrillator. J Cardiovasc Electrophysiol 2006;17:852-6.
7. Lee MA, Weachter R, Pollak S, Kremers MS, Naik AM, Silverman R et al. ATTEST investigators. The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency. Results of a randomized trial in patients with bradycardia and atrial tachyarrhythmias. J Am Coll Cardiol 2003;41:1926-32.
8. Israel CW, Gronefeld G, Ehrlich JR, Li YG, Hohnloser SH. Prevention of immediate reinitiation of atrial tachyarrhythmias by high-rate overdrive pacing: results from a prospective randomized trial. J Cardiovasc Electrophysiol 2003;14:954-9.
9. Gregoratos G, Abrans J, Epstein AE, Freedman RA, Hayes DL, HIatky MA et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines/North American Society for Pacing and Electrophysiology Committee to Update the 1998 Pacemaker Guidelines. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation 2002;106:61.
10. Israel CW, Hugl B, Unterberg C, Lawo T, Kennis I, Hettrick D et al. AT500 verification study investigators. Pace-termination and pacing for prevention of atrial tachyarrhythmias: results from a multicenter study with an implantable device for atrial therapy. J Cardiovasc Electrophysiol 2001;12:1121-8.
11. Gulizia M, Mangiameli S, Orazi S, Chiaranda G, Boriani G, Piccione G et al.PITAGORA investigators. Randomized comparison between Ramp and Burst+ atrial antitachycardia pacing therapies in patients suffering from sinus node disease and atrial fibrillation and implanted with a DDDRP device. Europace 2006;8:465-73.
12. Israel CW, Ehrlich JR, Gronefeld G, Klesius A, Lawo T, Lemke B et al. Prevalence, characteristics and clinical implications of regular atrial tachyarrhythmias in patients with atrial fibrillation: insights from a study using a new implantable device. J Am Coll Cardiol 2001;38:355-63.
13. Gillis AM, Rose MS. Temporal patterns of paroxysmal atrial fibrillation following DDDR pacemaker implantation. Am J Cardiol 2000;85:1445- 50.
14. Senn S. Cross-Over Trials in Clinical Research. West Sussex, England: John Wiley & Sons; 1993.
15. Lamas GA, Lee KL, Sweeney MO, Silverman R, Leon A, Yee R et al. Mode selection trial in sinus node diysfunction. Ventricular pacing or dual chamber pacing for sinus node dysfunction. N Engl J Med 2002;346:1854-62.
16. Connolly SJ, Kerr CR, Gent M, Roberts RS, Yusuf S, Gillis AM et al. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian trial of physiologic pacing investigators. N Engl J Med 2000;342:1385-91.
17. Friedman PA, Dijkman B, Warman EN, Xia HA, Mehra R, Stanton MS et al. Atrial therapies reduce atrial arrhythmia burden in defibrillator patients. Circulation 2001;104:1023-8.
18. Ricci R, Pignalberi C, Disertori M, Capucci A, Padeletti L, Botto G et al. Efficacy of a dual chamber defibrillator with atrial antitachycardia functions in treating spontaneous atrial tachyarrhythmias in patients with life-threatening ventricular tachyarrhythmias. Eur Heart J 2002;23:1471-9.
19. Hemels MEW, Wiesfeld ACP, Inberg B, Van Dessel P, Nieuwland W, Tan ES et al. Right atrial overdrive pacing for prevention of symptomatic refractory atrial fibrillation. Europace 2006;8:107-12.
20. Purerfellner H, Ruiter JH, Widdershoven JW, Van Gelder IC, Urban L, Kirchhof CJ et al., on behalf of PMOP investigators. Reduction of atrial tachyarrhythmia episodes during the overdrive pacing period using the post-mode switch overdrive pacing (PMOP) algorithm. Heart Rhythm 2006;3:1164-71.
21. Padeletti L, Santini M, Boriani G, Botto G, Capucci A, Gulizia M et al. Temporal variability of atrial tachyarrhythmia burden in bradycardiatachycardia syndrome patients. Eur Heart J 2005;26:165-72.
22. Botto GL, Santini M, Padeletti L, Boriani G, Luzzi G, Zolezzi F et al. Temporal variability of atrial fibrillation in pacemaker recipients for bradycardia: implications for crossover designed trials, study sample size, and identification of responder patients by means of arrhythmia burden. J Cardiovasc Electrophysiol 2007;18:250-7.
23. Chuang-Stein C. The regression fallacy. Drug Inf J 1993;27:1213-20.
24. Sweeney M, Bank A, Nsah E, Koullick M, Zeng Q, Hettrick D et al. Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease. N Engl J Med 2007;357:1000-8.
25. Lewalter T, Luderitz B. Atrial fibrillation: mortality, morbidity, and money; is that all? Importance and variability of burden measurement. Eur Heart J 2005;26:110-1.
26. Blanc J, De Royb L, Mansouratia J, Poezevarac Y, Marcond JL, Schoelse W et al. Atrial pacing for prevention of atrial fibrillation: assessment of simultaneously implemented algorithms. Europace 2004;6:371-9.